Today

Agents

Chat

Arena

Discover

More

App

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise - ETON News | Rallies

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise

ETON•2026-08-05

Reuters brief

Eton Pharmaceuticals Inc. ETON.O:
Eton Pharmaceuticals expands infantile hemangioma franchise with acquisition of U.S. rights to late-stage product candidate ASN-001
Eton Pharmaceuticals anticipates NDA submission for ASN-001 in 2H 2027, potential launch in 2028

Related News

Ball Corp raises target price to $66 from $65

BALL•2026-08-05

Netskope to report fiscal Q2 results after market close Sept. 2

NTSK•2026-08-05

Proposed Hormuz deal would give Iran control of inbound traffic, sources say

2026-08-05

Gartner, Inc. <IT.N>: UBS Raises Target Price to $196 From $164

IT•2026-08-05

Allegiant Travel Company <ALGT.O>: UBS Raises Target Price to $111 From $103

ALGT•2026-08-05